Immunosuppression by delta opioid receptor antagonist.
Arakawa
K
K
Second Department of Surgery, Kyoto Prefectural University of Medicine, Japan.
Akami
T
T
Okamoto
M
M
Akioka
K
K
Nakai
I
I
Oka
T
T
Nagase
H
H
D000818:Animals; D005455:Fluorescent Antibody Technique; D006085:Graft Survival / Q000187:drug effects* / Q000276:immunology; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007211:Indoles / Q000494:pharmacology*; D016030:Kidney Transplantation / Q000276:immunology*; D008213:Lymphocyte Activation / Q000187:drug effects; D007959:Lymphocyte Culture Test, Mixed; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology* / Q000378:metabolism; D009019:Morphinans / Q000494:pharmacology*; D009271:Naltrexone / Q000378:metabolism / Q000031:analogs & derivatives; D009292:Narcotic Antagonists / Q000494:pharmacology*; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D017465:Receptors, Opioid, delta / Q000037:antagonists & inhibitors*; D013154:Spleen / Q000276:immunology; D013997:Time Factors; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D007211:Indoles; D009019:Morphinans; D009292:Narcotic Antagonists; D017465:Receptors, Opioid, delta; D009271:Naltrexone; C055382:naltrindole